LB Pharmaceuticals

tenant

company

New York State Psychiatric Institute, Washington Heights Community Service

New York State Psychiatric Institute

as of 2026-07-01

Monitor this Ask about this

at a glance

43 trials sponsored · 53 assets in the graph

Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric

No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

53 assets

Clozapine Haloperidol Lumateperone (Caplyta)Olanzapine Paliperidone Pomaglumetad Risperidone Xanomeline-trospium (Cobenfy)Ziprasidone AVL-3288 Active Transcranial direct current stimulation (tDCS)Aerobic exercise Antidepressant Antipsychotic Auditory Remediation Benzodiazepine CSC OnDemand Training Intervention Case Management Clinic-Based Cognitive Remediation Cognitive Remediation Cognitive-Behavior Therapy Critical Time Intervention (CTI)Critical time intervention D-serine DAR 0-100A DAR-100A Data infrastructure InPerson Intervention Intensive Case Management Ketamine Hydrochloride Kuvan Lithium Mood stabilizer Multivitamin OTCH OnTrack>TheGame (OTG)Opening Doors to Recovery Partial-Remote Cognitive Remediation PsyGist and Clinician Manual Recovery Videos (RV)Simvastatin Social skills and symptom management training Stakeholder feedback Standard Psychiatric Treatment The Antipsychotic Medication Decision Aid (APM-DA)Tocilizumab Transcranial Magnetic Stimulation (TMS)Usual FEP Services Virtual InPerson Intervention ceftriaxone mHealth Intervention repetitive Transcranial Magnetic Stimulation transcranial direct current stimulation (tDCS)

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

asset

small molecule

drug

small molecule

drug

Lumateperone (Caplyta)

small molecule

drug

small molecule

drug

small molecule

drug

small molecule

drug

small molecule

drug

Xanomeline-trospium (Cobenfy)

small molecule

drug